These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 18077084

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N, Brown JM, Demcheva M, Kelley JR, Lockett MA, Vournakis J, Cole DJ.
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM, Lopes L, Ikeda Y, Bailey R, Barde I, Zenke M, Chain BM, Collins MK.
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [Abstract] [Full Text] [Related]

  • 8. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z, Ahmed KA, Hao S, Zhang X, Xie Y, Munegowda MA, Meng Q, Chibbar R, Xiang J.
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction of antitumor immunity using bone marrow-generated dendritic cells.
    Porgador A, Snyder D, Gilboa E.
    J Immunol; 1996 Apr 15; 156(8):2918-26. PubMed ID: 8609412
    [Abstract] [Full Text] [Related]

  • 12. The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signaling.
    Met O, Wang M, Pedersen AE, Nissen MH, Buus S, Claesson MH.
    Cancer Lett; 2006 Jan 18; 231(2):247-56. PubMed ID: 16399226
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.
    Diebold SS, Cotten M, Koch N, Zenke M.
    Gene Ther; 2001 Mar 18; 8(6):487-93. PubMed ID: 11313828
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
    Garg N, Nunes MP, Tarleton RL.
    J Immunol; 1997 Apr 01; 158(7):3293-302. PubMed ID: 9120286
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study.
    Zhou F, Rouse BT, Huang L.
    Cancer Res; 1992 Nov 15; 52(22):6287-91. PubMed ID: 1384958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.